iPierian

Careers Contact

  • Company
    • About Us
    • Leadership
      • Management Team
      • Board of Directors
      • Scientific Advisory Board
      • Key Advisors
    • Investors
    • Careers
      • Open Positions
    • Contact
  • Technology
    • Technology Overview
    • iPS Cell Technology
    • Differentiation
      • Proof of Concept
      • Advancing Cellular Programming
      • Scientific Advantages
    • Phenotypic Assay Development
  • Therapeutic Areas
    • Therapeutic Areas Overview
    • Neurological Diseases
    • Cardiovascular Disease
    • Metabolic Diseases
  • Collaborators
    • Collaborators Overview
  • News & Events
    • Newsroom
    • Press Releases
      • 2010
      • 2009
      • 2008
    • Media Kit
  • Newsroom
  • Press Releases
    • 2010
    • 2009
    • 2008
  • Media Kit

Newsroom

Print
Email

Media Inquiries

If you are a member of the media and have questions about company news announcements, interview requests, or other related inquiries, please contact:

Paul Laland
WeissComm Partners
415.946.1071
plaland@wcpglobal.com

Latest News


02/22/10
iPierian Appoints Dr. Michael Venuti as President and Chief Scientific Officer

01/28/10
First iPierian Patent for Induced Pluripotent Stem Cell Technology Granted by United Kingdom Intellectual Property Office

10/21/09
iPierian To Collaborate with Johns Hopkins University on $3.7 Million NIH Grand Opportunities Grant

09/01/09
iPierian Appoints Dr. Matthew J. Plunkett as Chief Financial Officer

View all press releases

© 2009 iPierian Inc. All rights reserved.

Home Site Map